Heart failure is commonin the elderly population.
Introduction
Heart failure (HF) is the pathophysiological state in which the heart is unable to pumpblood at a rate sufficient to meet metabolic demandsor can do so only from an elevated filling pres sure.
HFis commonin the elderly population. Approximately 6 to 10 percent of the population 65 years or older have HF (1) . In the Framingham study, the prevalence of HF was shown to rise progressively with age, from 1 percent of persons in their 50s to 10 percent of persons in their 80s (2, 3) (see Fig. 1 ). HFis the most commonreason for hospitalization in elderly patients (2, 3) . Approximately 80 percent of all HFadmissions occur in patients older than 65.
Etiology of HF in the Elderly
HFis a clinical syndrome and can be caused by virtually any form of heart disease. The distribution of causes of HF depends on what kind of patients with HF are selected. In the population-based study conducted in Framingham, MA,USA,the commoncauses of HFwere ischemic heart disease (54%), hypertensive heart disease (24%), and valvular heart disease (16%) (3). In a hospital-based study done in Fukuoka, Japan, the frequent causes of HF were ischemic heart disease (35%), valvular heart disease (28%), hypertensive heart disease (20%), and cardiomyopathy (19%) (4) (see Fig. 2 ). Differences in patient selection and/or racial variation mayexplain these results. Distribution of causes of HF in the elderly in Japan is thought to be similar to that in Fukuoka study since the mean age of patients was 69 years and 70 percent of the patients were >65 years of age, although it was not designed to specifically examine the elderly. Also, the etiology of HF in the elderly is often multifactorial as shown in the Fukuoka study.
Ischemic heart disease
Ischemic heart disease is the most commoncause of HF in the elderly. The severity and extent of coronary atherosclerosis increases with age, presumably as a result of prolonged exposure to coronary risk factors. Elderly patients more frequently have multivessel disease and lower ejection fraction than do younger patients (5). Non-Q wave myocardial infarction is relatively commonin the old population.
In the elderly, silent myocardial ischemia (presence of coronary artery disease without symptoms) is common.
Myocardial infarction may not be recognized by some of the elderly patients due to lack of chest discomfort. It maybe discovered only on subsequent routine ECG(unrecognized myocardial infarction). The prevalence of unrecognized myocardial infarction increases with age. In one study, unrecognized myocardial infarction was more than 5% prevalent in the group aged 75 to 79 years compared to nearly none in the youngest age group (6). Commoninitial presentation of myocardial infarction in the elderly is shortness of breath and easy fatiguability without symptomof chest pain. Age (years) Figure 1 . Prevalance rates of heart failure among
Framingham heart study subjects, by gender and age (3). Numbersdenote the percentage of patients to the total number of study patients (4).
Hypertensive heart disease
Hypertensive heart disease is a commoncause of HFin Plasma cell dyscrasia is responsible for the excess light chain production. Patients with AL amyloidosis have a poor prognosis with a median survival of 5.4 months when presented with HF.
Senile amyloidosis is not uncommon amongelderly patients with cardiac amyloidosis, although the exact incidence is not known. In senile amyloidosis, amyloid deposit consists of transthyretin, a transport protein for thyroxine and retinol- have a better prognosis with the actuarial median survival of 5 years compared to those with AL amyloidosis. These pa-tients should not be treated with chemotherapy because there is no tumor cell and chemotherapy will only do harm (14) . Therefore, it is very important to recognize the type of amyloidosis by performing immunohistochemical staining.
Congenital heart disease Atrial septal defect (ASD) is the most commoncongenital lesion in adults. While the patients with an ASDare often asymptomatic until adulthood, most patients with significant shunt flow will become symptomatic by the age of 40 (15) . Right ventricular failure can be the presenting symptomin older patients. Atrial arrhythmias increases with age and precipitates HF (16, 17) . In one study, for example, the incidence of atrial fibrillation or atrial flutter prior to surgery was 1 percent for those aged 18 to 40, 30 percent for those aged 40 to 60, and 80 percent in those over the age of 60 (16) .
Precipitating Factors of HF in the Elderly
Exacerbation of HF in patients with underlying heart disease is often accompanied by some of the following precipitating factors. Identification of these precipitating factors of HFis very important because an episode of HFcan often be terminated by treating a specific precipitating factor and may even be prevented by avoiding them.
A rrhythmia
Both tachyarrhythmia and bradyarrhythmia can precipitate HF.
The most common tachyarrhythmia in elderly population is atrial fibrillation (AF). The prevalence of AF was 9 percent in those 80 years of age compared to 0.1 percent among adults younger than 55 years of age (18) . Thus, AF is primarily a disease of older subjects. Loss of atrial booster pump function with AF impairs ventricular filling and loweres cardiac output. This loss of atrial contraction is particularly deleterious in elderly patients with a less compliant left ventricle. In addition, uncontrolled rapid ventricular responses with AF reduce the time available for ventricular filling. This exacerbates diastolic dysfunction and raises atrial pressure, thus precipitating HF.
The incidence of bradyarrhythmia, such as sick sinus syndrome and AVblock, also increases with age. This is probably due to age-associated fibrosis and sclerosis of the conduction system. Marked bradycardia in a patient with underlying heart disease depresses cardiac output, because stroke volume mayalready be maximum and cannot rise farther to maintain cardiac output.
Renal failure
Renal function deteriorates as people get old. Recent studies showed that renal dysfunction is an independent and important predictor of all-cause mortality in patients with HF (19, 20) . As renal failure impairs the ability of patients with heart failure to excrete sodiumand fluid, volumeoverload will develop and thus exacerbate HFsymptoms. Therefore, renal failure is an important precipitating factor of HF in the exacerbate preexisting HF. They are often prescribed for the elderly because of arthralgia. In a report of elderly patients with heart disease, there was a 10-fold increased risk of exacerbating HF of sufficient severity to require hospitalization in patients with recent NSAIDsuse, compared to those without such use; the risk was related to the dose of NSAIDs 
Diagnosis of HF in the Elderly
Diagnosis of HF may be difficult in the elderly. Symptoms of HFare often atypical or even absent in the elderly. Manyolder patients may not have dyspnea on exertion because of their sedentary lifestyle. Nonspecific complaints of generalized weakness, anorexia and fatigue often predominate. Some studies have reported that HF is the most frequent precipitating cause of delirium in older patients (24) . On the other hand, older patients with typical symptoms of HF are misdiagnosed with other diseases. For example, a dry cough or mild shortness of breath may be mistakenly attributed to chronic pulmonary disease. Easy fatiguability and generalized weakness may be wrongly thought merely to reflect changes associated with aging. Given the difficulties in making a diagnosis of HF in the elderly, the possibility of using a blood test to make a diagnosis of HF is appealing. Elevated plasma levels of brain natriuretic peptide (BNP) has been shown to be a reliable indicator of HF or LV dysfunction (25) . Maisel et al showed that BNPvalue of >100 pg/ ml was useful in establishing or excluding the diagnosis of HF in patients with acute dyspnea (26) . However, this may not apply to the elderly population. In recent population-based cohort study, Red field et al reported that BNPincreased significantly with age, especially in women (27) . For example, the 95th percentile range of BNPin healthy women aged >75 was 155 pg/ml in that study. Diagnosis of HFbased on the BNPvalue needs caution in the elderly.
Treatment of HF in the Elderly
Principles of treatment of HF in the elderly is the same as those in younger patients. First of all, identification of the underlying etiology and precipitating factors of HF is essential. Then, treatment aimed at retarding or reversing the underlying conditions that predispose to the development of HF should be employed to the degree possible. Several large-scale, randomized clinical trials have shown that various class of medications reduce the risk of death in patients with HF. Meanage of patients enrolled in these large HFtrials is listed on Table 1 . Patients enrolled in those trials are muchyounger than patients with HFin the real world. In addition, patients over 80 years of age are poorly represented in these trials (28) . Although these drugs are increasingly being used in older patients with HF, the efficacy of therapies remains uncertain in the very old. Future clinical trials should adequately include the elderly population that carry the burden of the disease. Systolic heart failure is usually managed by diuretics, angiotensin-converting enzyme inhibitors, digitalis and betablockers. Japanese Circulation Society issued a guideline for the treatment of HF (29) . Recommendation of therapy for HF according to the severity of symptoms is shown in Fig.  3 . The management of diastolic heart failure is discussed later.
Whenusing these drugs, it is important for physicians to take into consideration that the therapeutic range is narrowin treating elderly patients with HF. Elderly patients mayhave diminished responses to these medications comparedwith younger patients and mayexperience a higher risk of adverse effects attributable to treatment (30, 3 1).
As for the non-pharmacological aspects of management of HF, some multidisciplinary HF programs have been successful in decreasing the rate of rehospitalization and associated morbidity in elderly patients (32 mechanism of HF (34) . Heart failure associated with preserved systolic function is primarily a disease of elderly, most of whomhave hypertension (35) . This observation may be related to the fact that aging has a greater impact on diastolic function than on systolic performance (36) . Aging is associated with decreases in the elastic properties of the heart and great vessels, which leads to an increase in systolic blood pressure and an increase in myocardial stiffness. The rate of ventricular filling decreases in part because of structural changes in the heart (due to fibrosis) and because of a decline in active relaxation (due to an increase in afterload).
These deleterious effects on diastolic function are exacerbated by a decrease in beta-adrenergic receptor density and a decline in peripheral vasodilator capacity, both of which are characteristic of elderly patients. In addition, elderly patients commonlyhave associated disorders (such as coronary artery disease, diabetes mellitus, aortic stenosis, atrial fibrillation), which can adversely affect the diastolic properties of the heart or decrease the time available for ventricular filling.
In contrast to the treatment of HF due to systolic dysfunction, few clinical trials are available to guide the management of patients with HF due to diastolic dysfunction. In the absence of controlled clinical trials, the managementof patients with diastolic dysfunction is frequently determined by a set of therapeutic principles (37) . These include control of hypertension, control of tachycardia, reduction in central blood volume, and alleviation of myocardial ischemia. Hypertension exerts a deleterious effect on diastolic function by causing both structural and functional changes in the heart. Increases in systolic blood pressure have been shown to slow myocardial relaxation (38) , and the resulting hypertrophy may adversely affect passive chamber stiffness. Physicians should make every effort to control both systolic and diastolic hypertension with effective antihypertensive therapy. Tachycardia can shorten the time available for ventricular filling and coronary perfusion. Drugs that slow the heart rate or the ventricular response to atrial arrhythmias (eg, betablockers) can provide symptomatic relief in patients with diastolic dysfunction. Circulating blood volume is a major determinant of ventricular filling pressure. So the use of diuretics may improve breathlessness in patients with diastolic as well as systolic dysfunction.
Becausemyocardial ischemia can impair ventricular relaxation, coronary revascularization should be considered in patients with coronary artery disease in whomsymptomatic or demonstrable myocardial ischemia is believed to be exerting a deleterious effect on diastolic function.
Summary
HFis common in elderly population. The common causes of HFin the elderly are ischemic heart disease, valvular heart disease, hypertensive heart disease, and cardiomyopathy.
Exacerbation of HF is often accompanied by precipitating factors in the elderly. Making a diagnosis of HF may be difficult in the elderly because symptoms of HFare often atypical. Heart failure with preserved systolic function is common in the elderly. Basic principles of HF treatment in the elderly is similar to those in the young patients. 
